Exact Mass: 331.1199808

Exact Mass Matches: 331.1199808

Found 445 metabolites which its exact mass value is equals to given mass value 331.1199808, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ciprofloxacin

1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

C17H18FN3O3 (331.13321300000007)


Ciprofloxacin is only found in individuals that have used or taken this drug. It is a broad-spectrum antimicrobial carboxyfluoroquinoline.The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, strand supercoiling repair, and recombination. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 276 KEIO_ID C133; [MS3] KO008906 KEIO_ID C133; [MS2] KO008905 KEIO_ID C133 Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4]. Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].

   

Sekisanin

8H-[1,3]Dioxolo[6,7][2]benzopyrano[3,4-c]indol-6a(3H)-ol,4,4a,5,6-tetrahydro-3-methoxy-5-methyl-, (3S,4aS,6aS,13bS)-

C18H21NO5 (331.1419656)


   

Nizatidine

dimethyl[(4-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amine

C12H21N5O2S2 (331.1136606)


Nizatidine is only found in individuals that have used or taken this drug. It is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers. [PubChem]Nizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions. The drug also decreases the gastric acid response to stimuli such as food, caffeine, insulin, betazole, or pentagastrin. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Nizatidine is a potent and orally active histamine H2 receptor antagonist, can be used for the research of stomach?and?intestines ulcers. Nizatidine works by decreasing the secretion of gastric?acid the stomach makes and prevent ulcers from coming back after they have healed in animal models[1].

   

Pyridoxine O-glucoside

5-O-beta-D-Glucosylpyridoxine

C14H21NO8 (331.1267106)


   

malvidin

3 4 5 7-tetrahydroxy-3 5-dimethoxyflavylium chloride

[C17H15O7]+ (331.081774)


   

Ambelline

Crinan-18-ol, 1,2-didehydro-3,9-dimethoxy-, (3alpha,18S)-

C18H21NO5 (331.1419656)


   

Pretazettine

(1S,11R,13R,16S,18S)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraen-11-ol

C18H21NO5 (331.1419656)


Pretazettine, also known as pretazettine hydrochloride, (6abeta,8beta)-isomer, is a member of the class of compounds known as tazettine-type amaryllidaceae alkaloids. Tazettine-type amaryllidaceae alkaloids are amaryllidaceae alkaloids derived from the haemanthamine-type alkaloids, which are characterized as a linkage between C6 and C11 by an oxygen atom to form a [3,4-g]benzopyran framework. Pretazettine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Pretazettine can be found in lovage, which makes pretazettine a potential biomarker for the consumption of this food product.

   
   
   

2-O-Acetylpseudolycorine

2-O-Acetylpseudolycorine

C18H21NO5 (331.1419656)


   

Pitolisant hydrochloride

Pitolisant hydrochloride

C17H27Cl2NO (331.1469592)


C78272 - Agent Affecting Nervous System Pitolisant hydrochloride is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).

   

zotepine

zotepine

C18H18ClNOS (331.07975680000004)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM and 8 nM, respectively. Zotepine exhibits antidepressive and anxiolytic effects in vivo[1][2].

   

Alitame

3-Amino-3-({1-[(2,2,4,4-tetramethylthietan-3-yl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)propanoate

C14H25N3O4S (331.15656900000005)


Alitame is a sweetening agent. It is intensely sweet, approximately 2000 times sweeter than sucrose. Its use is currently (1999) permitted in Australia, New Zealand, Indonesia and China. Alitame is an artificial sweetener developed by Pfizer in the early 1980s and currently marketed in some countries under the brand name Aclame. Like aspartame, alitame is an aspartic acid-containing dipeptide. Most dipeptides are not sweet, but the unexpected discovery of aspartame in 1965 led to a search for similar compounds that shared its sweetness. Alitame is one such second-generation dipeptide sweetener. Neotame, developed by the owners of the NutraSweet brand, is another. Sweetening agent. Intensely sweet, approx. 2000 x sucrose. Use currently (1999) permitted in Australia, New Zealand, Indonesia and China

   

Citbrasine

1,5-dihydroxy-2,3,4-trimethoxy-10-methyl-9,10-dihydroacridin-9-one

C17H17NO6 (331.1055822)


Citbrasine is found in citrus. Citbrasine is an alkaloid from the root bark of Citrus sinensis var. brasiliensis (navel orange). Alkaloid from the root bark of Citrus sinensis variety brasiliensis (navel orange). Citbrasine is found in citrus.

   

R-95913

1-cyclopropyl-2-(2-fluorophenyl)-2-{2-hydroxy-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}ethan-1-one

C18H18FNO2S (331.10422200000005)


R-95913 is only found in individuals that have used or taken Prasugrel. R-95913 is a metabolite of Prasugrel. R-95913 belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.

   

5'-O-Desmethyl omeprazole

2-[(4-Methoxy-3,5-dimethylpyridin-2-yl)methanesulphinyl]-1H-1,3-benzodiazol-6-ol

C16H17N3O3S (331.09905720000006)


5-O-Desmethyl omeprazole is only found in individuals that have used or taken Omeprazole. 5-O-Desmethyl omeprazole is a metabolite of Omeprazole. 5-o-desmethyl omeprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

N'-Hydroxyneosaxitoxin

{5,10,10-trihydroxy-2,6-diimino-decahydropyrrolo[1,2-c]purin-4-yl}methyl N-hydroxycarbamate

C10H17N7O6 (331.1240262)


N-Hydroxyneosaxitoxin is isolated from the crab Zosimus aeneus. Isolated from the crab Zosimus aeneus.

   

6-Hydroxyoct-2-enedioylcarnitine

3-[(7-carboxy-6-hydroxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


6-hydroxyoct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyoct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyoct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyoct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyoct-3-enedioylcarnitine

3-[(7-carboxy-6-hydroxyhept-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


6-hydroxyoct-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyoct-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyoct-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyoct-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyoct-3-enedioylcarnitine

3-[(7-carboxy-7-hydroxyhept-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


7-hydroxyoct-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyoct-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-hydroxyoct-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-hydroxyoct-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyoct-4-enedioylcarnitine

3-[(7-carboxy-7-hydroxyhept-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


7-hydroxyoct-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyoct-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-hydroxyoct-4-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-hydroxyoct-4-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyoct-2-enedioylcarnitine

3-[(7-carboxy-5-hydroxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


5-hydroxyoct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyoct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-hydroxyoct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-hydroxyoct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2R,3R,4S,5S,6R)-6-[[5-Hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxymethyl]oxane-2,3,4,5-tetrol

(2R,3R,4S,5S,6R)-6-[[5-Hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxymethyl]oxane-2,3,4,5-tetrol

C14H21NO8 (331.1267106)


   

5'-O-beta-D-Glucosylpyridoxine

2-{[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H21NO8 (331.1267106)


   

7-Chloro-N-[3-(2-nitroimidazol-1-yl)propyl]quinolin-4-amine

7-chloro-N-[3-(2-nitro-1H-imidazol-1-yl)propyl]quinolin-4-amine

C15H14ClN5O2 (331.0835974)


   

(R)-2-Amino-3-benzylthio-N-(4-nitrophenyl)propionamide

2-amino-3-(benzylsulfanyl)-N-(4-nitrophenyl)propanamide

C16H17N3O3S (331.09905720000006)


   

(E)-2-(3-(Naphthalen-2-yl)but-2-enamido)benzoic acid

2-[[3-(2-Naphthalenyl)-1-oxobut-2-enyl]amino]benzoate

C21H17NO3 (331.1208372)


   

4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine

4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine

C19H22FNO3 (331.1583634)


   

Chlorprothixene sulfoxide

2-chloro-9-[3-(dimethylamino)propylidene]-9H-10lambda4-thioxanthen-10-one

C18H18ClNOS (331.07975680000004)


   

Didesethylflurazepam

1-(2-aminoethyl)-7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C17H15ClFN3O (331.0887622)


   

(2S,3S)-2-(2,4-Difluorophenyl)-3-methylsulfonyl-1-(1,2,4-triazol-1-yl)butan-2-ol

Threo-2-(2,4-difluorophenyl)-3-methylsulfonyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

C13H15F2N3O3S (331.08021440000005)


   

Ggstop

2-Amino-4-((3-(carboxymethyl)phenyl)(methyl)phosphono)butanoic acid

C13H18NO7P (331.0820848)


   

Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide

13-Chloro-N-(1-hydroxyethylidene)-2-oxa-9-azatricyclo[9.4.0.0,]pentadeca-1(15),3,5,7,11,13-hexaene-9-carbohydrazonate

C16H14ClN3O3 (331.07236439999997)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole

4-[4-(4-fluorophenyl)-5-(pyridin-4-yl)-3H-imidazol-2-yl]phenol

C20H14FN3O (331.1120846)


   

N'-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

6-Chloro-N-(1-hydroxyethylidene)-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-9-carbohydrazonate

C16H14ClN3O3 (331.07236439999997)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

4H-1,2,4-Triazole, 3-(trans-1-(4-chlorophenyl)-3-fluorocyclobutyl)-4,5-dicyclopropyl-

4H-1,2,4-Triazole, 3-(trans-1-(4-chlorophenyl)-3-fluorocyclobutyl)-4,5-dicyclopropyl-

C18H19ClFN3 (331.1251456)


   

Axid Ar

1-N-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulphanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine

C12H21N5O2S2 (331.1136606)


   

zotepine

[2-({6-chloro-2-thiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-9-yl}oxy)ethyl]dimethylamine

C18H18ClNOS (331.07975680000004)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM and 8 nM, respectively. Zotepine exhibits antidepressive and anxiolytic effects in vivo[1][2].

   

16alpha, 17-epoxy gibberellin A9

(2R,2R,5R,8R,9S,10R,11S)-11-methyl-16-oxo-15-oxaspiro[oxirane-2,6-pentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane]-9-carboxylate

C19H23O5- (331.1545408)


16alpha, 17-epoxy gibberellin a9 is also known as 16α, 17-epoxy ga9. 16alpha, 17-epoxy gibberellin a9 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16alpha, 17-epoxy gibberellin a9 can be found in a number of food items such as mugwort, natal plum, radish, and prickly pear, which makes 16alpha, 17-epoxy gibberellin a9 a potential biomarker for the consumption of these food products. 16α, 17-epoxy gibberellin a9 is also known as 16α, 17-epoxy ga9. 16α, 17-epoxy gibberellin a9 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16α, 17-epoxy gibberellin a9 can be found in a number of food items such as mugwort, natal plum, radish, and prickly pear, which makes 16α, 17-epoxy gibberellin a9 a potential biomarker for the consumption of these food products.

   

4-hydroxy-2-nonenal-[Cys-Gly] conjugate

{1-[(carboxylatomethyl)carbamoyl]-2-[(4-hydroxy-1-oxononan-3-yl)sulfanyl]ethyl}azaniumyl

C14H23N2O5S (331.1327608)


4-hydroxy-2-nonenal-[cys-gly] conjugate is a member of the class of compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 4-hydroxy-2-nonenal-[cys-gly] conjugate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 4-hydroxy-2-nonenal-[cys-gly] conjugate can be found in a number of food items such as persian lime, silver linden, black raspberry, and nutmeg, which makes 4-hydroxy-2-nonenal-[cys-gly] conjugate a potential biomarker for the consumption of these food products.

   
   
   

(+)-O9-Demethyl-5a-methoxyhomolycorine

(+)-5-Methoxy-9-O-demethylhomolycorine

C18H21NO5 (331.1419656)


   

11-hydroxycephalotaxine

11alpha-Hydroxycephalotaxine

C18H21NO5 (331.1419656)


   
   
   
   
   

5alpha-Hydroxyhomolycorine

5alpha-Hydroxyhomolycorine

C18H21NO5 (331.1419656)


   
   
   
   
   
   

Pseudolycorine 1-acetate

Pseudolycorine 1-acetate

C18H21NO5 (331.1419656)


   
   
   

Norprostephabyssine

Norprostephabyssine

C18H21NO5 (331.1419656)


   

Cephalotaxine beta-N-oxide

Cephalotaxine beta-N-oxide

C18H21NO5 (331.1419656)


   
   

6-O-Methylhaemanthidine

6-O-Methylhaemanthidine

C18H21NO5 (331.1419656)


   

Pyridoxine 5-glucoside

Pyridoxine 5-glucoside

C14H21NO8 (331.1267106)


   
   

Europinidin

3,7,3,4-Tetrahydroxy-5,5-dimethoxyflavylium

C17H15O7 (331.081774)


   

N1-(3-Methoxyphenyl)-2-cyano-3-(4-methylpiperidino)-3-oxopropanethioamide

N1-(3-Methoxyphenyl)-2-cyano-3-(4-methylpiperidino)-3-oxopropanethioamide

C17H21N3O2S (331.13544060000004)


   

O1-[(3,5-Dimethylisoxazol-4-yl)carbonyl]-2-[3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanehydroximamide

O1-[(3,5-Dimethylisoxazol-4-yl)carbonyl]-2-[3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanehydroximamide

C12H12F3N5O3 (331.0892198)


   
   
   
   
   

Tributyltin chloride; Tri-n-butylchlorotin; Tributylchlorostannane

Tributyltin chloride; Tri-n-butylchlorotin; Tributylchlorostannane

C12H32ClSn+ (331.1214392)


   

Zinolol

Zinolol

C14H21NO8 (331.1267106)


A monosaccharide derivative that is 1,4-dihydroxybenzene substituted by a (methylamino)methyl group at position 6 and a beta-D-glucopyranosyloxy residue at position 2. Isolated from Anagallis monelli, it exhibits antimutagenic and antioxidant activities.

   
   
   

(1R,2S,4aR,10bR)-10b-hydroxyhippeastrine|pancratinine A

(1R,2S,4aR,10bR)-10b-hydroxyhippeastrine|pancratinine A

C17H17NO6 (331.1055822)


   

Haploperine;Haploperin; Haplophytin B; Haplophytine B; NSC 94653

Haploperine;Haploperin; Haplophytin B; Haplophytine B; NSC 94653

C18H21NO5 (331.1419656)


   
   
   
   

Cephalotaxine, 15-hydroxy-

Cephalotaxine, 15-hydroxy-

C18H21NO5 (331.1419656)


   
   

4-Hydroxycephalotaxine

4-Hydroxycephalotaxine

C18H21NO5 (331.1419656)


   

N-methylschumannificine

N-methylschumannificine

C17H17NO6 (331.1055822)


   
   

5alpha,11-dihydroxy-9,10-methanediyldioxy-1-methyl-lycoran-4(12)-en-7-one|Nor-Neronin|norneronine|O-demethyl-neronine

5alpha,11-dihydroxy-9,10-methanediyldioxy-1-methyl-lycoran-4(12)-en-7-one|Nor-Neronin|norneronine|O-demethyl-neronine

C17H17NO6 (331.1055822)


   
   
   
   
   

1,6-dihydroxy-2,3,5-trimethoxy-10-methyl-9-acridone|1,6-Dihydroxy-2,3,5-trimethoxy-10-methylacridone

1,6-dihydroxy-2,3,5-trimethoxy-10-methyl-9-acridone|1,6-Dihydroxy-2,3,5-trimethoxy-10-methylacridone

C17H17NO6 (331.1055822)


   
   

2-O-methylclivonine

2-O-methylclivonine

C18H21NO5 (331.1419656)


   

6-methoxy-7-(2-methoxy-3-methyl-but-3-enyl)-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Me ether -Ptelefolidine|O-methyl-ptelefolidine|Ptelefolidinmethylether

6-methoxy-7-(2-methoxy-3-methyl-but-3-enyl)-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Me ether -Ptelefolidine|O-methyl-ptelefolidine|Ptelefolidinmethylether

C18H21NO5 (331.1419656)


   

6-Hydroxy-buphanidrine

6-Hydroxy-buphanidrine

C18H21NO5 (331.1419656)


   

2alpha-hydroxy-6-O-methyloduline

2alpha-hydroxy-6-O-methyloduline

C18H21NO5 (331.1419656)


   

4,8-dimethoxy-5-methyl-7-(3-methyl-but-2-enyl)-5H-[1,3]dioxolo[4,5-g]quinolin-6-one|Ptelecortin|Ptelecortine

4,8-dimethoxy-5-methyl-7-(3-methyl-but-2-enyl)-5H-[1,3]dioxolo[4,5-g]quinolin-6-one|Ptelecortin|Ptelecortine

C18H21NO5 (331.1419656)


   
   

7alpha-hydroxy-erythratine|cristanine B

7alpha-hydroxy-erythratine|cristanine B

C18H21NO5 (331.1419656)


   

13-Methyl-2-methoxy-7,8-dihydroindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(13H)-one

13-Methyl-2-methoxy-7,8-dihydroindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(13H)-one

C20H17N3O2 (331.1320702)


   
   

Crinamine,6-methoxy-

Crinamine,6-methoxy-

C18H21NO5 (331.1419656)


   

1-(4,8-dimethoxy-furo[2,3-b]quinolin-7-yloxy)-3-methyl-butan-2-ol|dihydro-evodine|dihydro-evoxoidine|Dihydroevoxoidin|evodine

1-(4,8-dimethoxy-furo[2,3-b]quinolin-7-yloxy)-3-methyl-butan-2-ol|dihydro-evodine|dihydro-evoxoidine|Dihydroevoxoidin|evodine

C18H21NO5 (331.1419656)


   
   

11,11-dihydroxy-saxitoxin|M4

11,11-dihydroxy-saxitoxin|M4

C10H17N7O6 (331.1240262)


   

10-Methoxy-14-methyl-5-oxo-5,7,8,14-tetrahydro-indolo-[2,3-c]-quinazo-[3,2,a]-pyridine

10-Methoxy-14-methyl-5-oxo-5,7,8,14-tetrahydro-indolo-[2,3-c]-quinazo-[3,2,a]-pyridine

C20H17N3O2 (331.1320702)


   
   

Z-Phe-chloromethylketone

Z-Phe-chloromethylketone

C18H18ClNO3 (331.0975148)


   

n-aminooxymethylcarbonylhydrazino-d-biotin

n-aminooxymethylcarbonylhydrazino-d-biotin

C12H21N5O4S (331.1314186000001)


   

MY-5445

1-Phthalazinamine, N-(3-chlorophenyl)-4-phenyl-

C20H14ClN3 (331.08761940000005)


MY-5445 is a specific inhibitor of the cyclic GMP phosphodiesterase, phosphodiesterase type 5 (PDE5), with a Ki of 1.3 μM. MY-5445 inhibits human platelet aggregation. MY-5445 is a selective modulator of ATP-binding cassette (ABC) transporter ABCG2, with anti-proliferative effect[1][2].

   

ciprofloxacin

Ciprofloxacin - Dark Web Drugs

C17H18FN3O3 (331.13321300000007)


A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; INTERNAL_ID 1026 Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4]. Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].

   

Alitame

3-amino-3-({1-[(2,2,4,4-tetramethylthietan-3-yl)carbamoyl]ethyl}carbamoyl)propanoic acid

C14H25N3O4S (331.15656900000005)


CONFIDENCE standard compound; INTERNAL_ID 5808

   

C18H21NO5_Tazettine

8H-[1,3]Dioxolo[6,7][2]benzopyrano[3,4-c]indol-6a(3H)-ol,4,4a,5,6-tetrahydro-3-methoxy-5-methyl-, (3S,4aS,6aS,13bS)-

C18H21NO5 (331.1419656)


   

Nizatidine

Nizatidine

C12H21N5O2S2 (331.1136606)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents

   
   

Pyridoxine + O-Hex

Pyridoxine + O-Hex

C14H21NO8 (331.1267106)


Annotation level-3

   

Tazettine

(1S,13S,16R,18S)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.01,16.02,10.04,8]icosa-2,4(8),9,19-tetraen-13-ol

C18H21NO5 (331.1419656)


Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Amaryllidaceae alkaloids

   

N4-Benzoyl-deoxycytidine

N4-Benzoyl-deoxycytidine

C16H17N3O5 (331.1168152)


   

N6-(Furan-2-yl)methyl-deoxyadenosine

N6-(Furan-2-yl)methyl-deoxyadenosine

C15H17N5O4 (331.1280482)


   

Ala Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Gln Gly

2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Ala Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Ala Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gln Gly Gly

2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]propanamido]-3-carbamoylpropanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetamido}-4-carbamoylbutanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Gln Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gly Ala Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanamido]-4-carbamoylbutanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gly Gln Ala

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Asn Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gln Ala Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gln Gly Ala

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}propanoic acid

C12H21N5O6 (331.14917660000003)


   

4-(4-Fluorophenyl)-3-(4-methoxy-3-hydroxyphenoxymethyl)piperidine

5-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol

C19H22FNO3 (331.1583634)


   

(-)-tramadol

4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol

C19H22FNO3 (331.1583634)


   

Asn Ala Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Asn Ala Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}propanoic acid

C12H21N5O6 (331.14917660000003)


   

Asn Gly Ala Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gln Ala Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}acetic acid

C12H21N5O6 (331.14917660000003)


   

Gln Gly Ala Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Gln Gly Gly Ala

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)propanoic acid

C12H21N5O6 (331.14917660000003)


   
   

zpck

1-BENZYLOXYCARBONYLAMINOPHENETHYL CHLOROMETHYL KETONE

C18H18ClNO3 (331.0975148)


   

SC-19220

8-chloro-dibenz[b,f][1,4]oxazepine-10(11H)-carboxy-(2-acetyl)hydrazide

C16H14ClN3O3 (331.07236439999997)


   

Aldehyde Reactive Probe

(6aR)-hexahydro-2-oxo-2-[(aminooxy)acetyl]hydrazide,1H-thieno[3aS,4S-d]imidazole-4-pentanoic acid

C12H21N5O4S (331.1314186000001)


   

R-95913

1-cyclopropyl-2-(2-fluorophenyl)-2-{2-hydroxy-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}ethan-1-one

C18H18FNO2S (331.10422200000005)


   

5-O-Desmethyl omeprazole

2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazol-6-ol

C16H17N3O3S (331.09905720000006)


   

N'-Hydroxyneosaxitoxin

N'-Hydroxyneosaxitoxin

C10H17N7O6 (331.1240262)


   

Citbrasine

1,5-dihydroxy-2,3,4-trimethoxy-10-methyl-9,10-dihydroacridin-9-one

C17H17NO6 (331.1055822)


   

malvidin

malvidin

C17H15O7+ (331.081774)


An anthocyanidin cation that is delphinidin carrying methyl substituents at positions 3 and 5.

   

2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine

2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine

C18H21NO3S (331.12420760000003)


   

N-benzyl-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine

N-benzyl-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine

C21H18FN3 (331.148468)


   

3-[3-acetyl-4-hydroxy-5-oxo-2-(4-propan-2-ylphenyl)-2H-pyrrol-1-yl]propanoic acid

3-[3-acetyl-4-hydroxy-5-oxo-2-(4-propan-2-ylphenyl)-2H-pyrrol-1-yl]propanoic acid

C18H21NO5 (331.1419656)


   

7-chloro-4-(4-methylpiperazin-1-yl)-10H-thieno[3,2-c][1]benzazepine

7-chloro-4-(4-methylpiperazin-1-yl)-10H-thieno[3,2-c][1]benzazepine

C17H18ClN3S (331.09098980000005)


   

Flazalone

Methanone,(4-fluorophenyl)[4-(4-fluorophenyl)-4-hydroxy-1-methyl-3-piperidinyl]-

C19H19F2NO2 (331.1383778)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   
   

4-chlorophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside

4-chlorophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside

C14H18ClNO6 (331.0822598)


   

4-[(3-acetoxypropyl)amino]-2,2-dimethyl-4-oxobutane-1,3-diyl diacetate

4-[(3-acetoxypropyl)amino]-2,2-dimethyl-4-oxobutane-1,3-diyl diacetate

C15H25NO7 (331.163094)


   

Esmolol hydrochloride

Esmolol hydrochloride

C16H26ClNO4 (331.15502660000004)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Esmolol hydrochloride is a beta adrenergic receptor blocker.

   

TETRAETHYL DIMETHYLAMINOMETHYLENEDIPHOSPHONATE

TETRAETHYL DIMETHYLAMINOMETHYLENEDIPHOSPHONATE

C11H27NO6P2 (331.1313542)


   

Dibenzepin hydrochloride

11H-Dibenzo[b,e][1,4]diazepin-11-one,10-[2-(dimethylamino)ethyl]-5,10-dihydro-5-methyl-, hydrochloride (1:1)

C18H22ClN3O (331.14513120000004)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

Ethyl 4-(benzyloxy)-7-cyano-2-naphthoate

Ethyl 4-(benzyloxy)-7-cyano-2-naphthoate

C21H17NO3 (331.1208372)


   

4-[2-[[(4-Methylphenyl)sulfonyl]oxy]ethyl]-1,3-dihydro-2H-indole-2-one

4-[2-[[(4-Methylphenyl)sulfonyl]oxy]ethyl]-1,3-dihydro-2H-indole-2-one

C17H17NO4S (331.08782420000006)


   

N-Benzoyl-L-argininamide hydrochloride monohydrate

N-Benzoyl-L-argininamide hydrochloride monohydrate

C13H22ClN5O3 (331.14110919999996)


   

n-tritylglycine methyl ester

n-tritylglycine methyl ester

C22H21NO2 (331.1572206)


   
   

4-(4-benzylpiperidin-1-yl)quinazoline-6-carbaldehyde

4-(4-benzylpiperidin-1-yl)quinazoline-6-carbaldehyde

C21H21N3O (331.1684536)


   

(R)-1-Benzyl-3-[(p-tolylsulfonyl)oxy]pyrrolidine

(R)-1-Benzyl-3-[(p-tolylsulfonyl)oxy]pyrrolidine

C18H21NO3S (331.12420760000003)


   

7-Methoxycoumarin-4-acetyl-L-proline

7-Methoxycoumarin-4-acetyl-L-proline

C17H17NO6 (331.1055822)


   

4-(ISOCYANO(TOSYL)METHYL)-1,2-DIMETHOXYBENZENE

4-(ISOCYANO(TOSYL)METHYL)-1,2-DIMETHOXYBENZENE

C17H17NO4S (331.08782420000006)


   

Uracil,6-amino-5-[2-(benzylmethylamino)acetamido]-1,3-dimethyl- (6CI)

Uracil,6-amino-5-[2-(benzylmethylamino)acetamido]-1,3-dimethyl- (6CI)

C16H21N5O3 (331.16443160000006)


   
   

Dothiepin HCl

trans-Prothiadene hydrochloride

C19H22ClNS (331.1161402000001)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   
   

L-Phenylalanine,N-(2,4-dinitrophenyl)-

L-Phenylalanine,N-(2,4-dinitrophenyl)-

C15H13N3O6 (331.08043180000004)


   

2-AMINO-BENZOIC ACID 2-BIPHENYL-4-YL-2-OXO-ETHYL ESTER

2-AMINO-BENZOIC ACID 2-BIPHENYL-4-YL-2-OXO-ETHYL ESTER

C21H17NO3 (331.1208372)


   

2-(2-METHOXY-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

2-(2-METHOXY-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C20H17N3O2 (331.1320702)


   

2-(3-METHOXY-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

2-(3-METHOXY-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C20H17N3O2 (331.1320702)


   

SB 202190

4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole

C20H14FN3O (331.1120846)


D004791 - Enzyme Inhibitors

   

6-(3-ACETYL-4-HYDROXY-5-OXO-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANOIC ACID

6-(3-ACETYL-4-HYDROXY-5-OXO-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANOIC ACID

C18H21NO5 (331.1419656)


   
   

3,4,6-TRI-O-ACETYL-2-AZIDO-2-DEOXY-D-GALACTOSE

3,4,6-TRI-O-ACETYL-2-AZIDO-2-DEOXY-D-GALACTOSE

C12H17N3O8 (331.1015602)


   

3-DIMETHYLAMINO-2-[1-(4-METHOXY-BENZYL)-1H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

3-DIMETHYLAMINO-2-[1-(4-METHOXY-BENZYL)-1H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

C16H21N5O3 (331.16443160000006)


   

5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one

5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one

C18H18FNO2S (331.10422200000005)


   

2-(TETRAHYDRO-FURAN-2-YL)-N-(3-TRIFLUOROMETHYL-PHENYL)-SUCCINAMIC ACID

2-(TETRAHYDRO-FURAN-2-YL)-N-(3-TRIFLUOROMETHYL-PHENYL)-SUCCINAMIC ACID

C15H16F3NO4 (331.10313720000005)


   

2-(2-FLUOROACETAMIDO)-5-NITRO-N-(O-TOLYL)BENZAMIDE

2-(2-FLUOROACETAMIDO)-5-NITRO-N-(O-TOLYL)BENZAMIDE

C16H14FN3O4 (331.09682960000004)


   

Protokylol

4-[2-[1-(1,3-benzodioxol-5-yl)propan-2-ylamino]-1-hydroxyethyl]benzene-1,2-diol

C18H21NO5 (331.1419656)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

1-((3-ETHYL-2(3H)-BENZOTHIAZOLYLIDENE)-&

1-((3-ETHYL-2(3H)-BENZOTHIAZOLYLIDENE)-&

C21H17NOS (331.1030792)


   

1-Benzyl-4-(piperidin-4-yl)piperazine dihydrochloride

1-Benzyl-4-(piperidin-4-yl)piperazine dihydrochloride

C16H27Cl2N3 (331.15819220000003)


   

1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate

1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate

C11H16F3NO5S (331.0701242)


   

[4-(4-chloro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

[4-(4-chloro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

C17H18ClN3O2 (331.1087478)


   

3-DIMETHYLAMINO-2-[2-(4-METHOXY-BENZYL)-2H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

3-DIMETHYLAMINO-2-[2-(4-METHOXY-BENZYL)-2H-TETRAZOL-5-YL]-ACRYLIC ACID ETHYL ESTER

C16H21N5O3 (331.16443160000006)


   

1-(4-TOLUENENSULFONYLAMINO)-2,6-DIISOPROPYLBENZENE

1-(4-TOLUENENSULFONYLAMINO)-2,6-DIISOPROPYLBENZENE

C19H25NO2S (331.160591)


   

5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-3,4,6,7-tetrahydrothieno[3,2-c]pyridin-2-one

5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-3,4,6,7-tetrahydrothieno[3,2-c]pyridin-2-one

C18H18FNO2S (331.10422200000005)


   

TERT-BUTYL(R)-(+)-4-FORMYL-2,2-DIMETHYL-3-OXAZOLIDINECARBOXYLATE

TERT-BUTYL(R)-(+)-4-FORMYL-2,2-DIMETHYL-3-OXAZOLIDINECARBOXYLATE

C16H20F3NO3 (331.1395206000001)


   

BIBR 1532

(E)-2-(3-(Naphthalen-2-yl)but-2-enamido)benzoic acid

C21H17NO3 (331.1208372)


   

1-amino-4-hydroxy-2-phenoxyanthraquinone

1-amino-4-hydroxy-2-phenoxyanthraquinone

C20H13NO4 (331.08445380000006)


   

4-chloro-7-methoxy-5-[(1-methyl-4-piperidyl)oxy]quinoline-3-carbo nitrile

4-chloro-7-methoxy-5-[(1-methyl-4-piperidyl)oxy]quinoline-3-carbo nitrile

C17H18ClN3O2 (331.1087478)


   

(S)-1-Benzyl-3-[(p-tolylsulfonyl)oxy]pyrrolidine

(S)-1-Benzyl-3-[(p-tolylsulfonyl)oxy]pyrrolidine

C18H21NO3S (331.12420760000003)


   

N-Benzoyl-2-deoxy-cytidine

N-Benzoyl-2-deoxy-cytidine

C16H17N3O5 (331.1168152)


   

PROPIONYLCHOLINE P-TOLUENESULFONATE

PROPIONYLCHOLINE P-TOLUENESULFONATE

C15H25NO5S (331.14533600000004)


   

Benzenemethanamine,N-[bis(4-methoxyphenyl)methylene]-

Benzenemethanamine,N-[bis(4-methoxyphenyl)methylene]-

C22H21NO2 (331.1572206)


   

norfluoxetine hydrochloride

norfluoxetine hydrochloride

C16H17ClF3NO (331.09506980000003)


Norfluoxetine hydrochloride is an active N-demethylated metabolite of Fluoxetine. Fluoxetine is a selective serotonin (5-HT) reuptake inhibitor that is metabolized to Norfluoxetine hydrochloride by cytochrome P450 (CYP) 2D6, CYP2C19, and CYP3A4. Norfluoxetine hydrochloride inhibits 5-HT uptake and inhibits CaV3.3 T current (IC50 = 5 μM). Norfluoxetine hydrochloride has anticonvulsant activity[1][2][3][4].

   

1-Benzyl-7-phenyl-1H-pyrimido[4,5-d][1,3]oxazine-2,4-dione

1-Benzyl-7-phenyl-1H-pyrimido[4,5-d][1,3]oxazine-2,4-dione

C19H13N3O3 (331.09568680000007)


   

tert-butyl 5-(trifluoromethylsulfonyloxy)-3,6-dihydro-2H-pyridine-1-carboxylate

tert-butyl 5-(trifluoromethylsulfonyloxy)-3,6-dihydro-2H-pyridine-1-carboxylate

C11H16F3NO5S (331.0701242)


   

(1.ALPHA.,3A.ALPHA.,6A.ALPHA.)-HEXAHYDRO-4-OXO-CYCLOPENTA[C]PYRROLE-1,2(1H)-DICARBOXYLIC ACID-1-ETHYL2-(PHENYLMETHYL) ESTER

(1.ALPHA.,3A.ALPHA.,6A.ALPHA.)-HEXAHYDRO-4-OXO-CYCLOPENTA[C]PYRROLE-1,2(1H)-DICARBOXYLIC ACID-1-ETHYL2-(PHENYLMETHYL) ESTER

C18H21NO5 (331.1419656)


   

tert-butyl 4-(2,6-dichloropyridin-4-yl)piperazine-1-carboxylate

tert-butyl 4-(2,6-dichloropyridin-4-yl)piperazine-1-carboxylate

C14H19Cl2N3O2 (331.0854254)


   

1-Benzhydryl-3-methanesulfonyloxy-3-methylazetidine

1-Benzhydryl-3-methanesulfonyloxy-3-methylazetidine

C18H21NO3S (331.12420760000003)


   

azanium,1,2-bis(ethenyl)benzene,2-ethenylbenzenesulfonate

azanium,1,2-bis(ethenyl)benzene,2-ethenylbenzenesulfonate

C18H21NO3S (331.12420760000003)


   

dimethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

dimethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

C18H21NO5 (331.1419656)


   
   

4-Nitro-N-[2-(4-nitrophenoxy)ethyl]benzeneethanamine

4-Nitro-N-[2-(4-nitrophenoxy)ethyl]benzeneethanamine

C16H17N3O5 (331.1168152)


   

1-ethenyl-3-methylimidazol-3-ium,1-ethenylpyrrolidin-2-one,methyl sulfate

1-ethenyl-3-methylimidazol-3-ium,1-ethenylpyrrolidin-2-one,methyl sulfate

C13H21N3O5S (331.1201856)


   

N-cyclopentyl-2-methyl-5-(4-methylsulfonylphenyl)pyrimidin-4-amine

N-cyclopentyl-2-methyl-5-(4-methylsulfonylphenyl)pyrimidin-4-amine

C17H21N3O2S (331.13544060000004)


   

(+-)-Benzyloxycarbonyl-alpha-phosphonoglycinetrimethylester

(+-)-Benzyloxycarbonyl-alpha-phosphonoglycinetrimethylester

C13H18NO7P (331.0820848)


   

(2Z)-2-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]-2-[(4S)-4-phenyl-1,3-oxazolidin-2-ylidene]acetonitrile

(2Z)-2-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]-2-[(4S)-4-phenyl-1,3-oxazolidin-2-ylidene]acetonitrile

C20H17N3O2 (331.1320702)


   

2-METHYL-5-PHENYL-3-(3-SULFOPROPYL)BENZOXAZOLIUM HYDROXIDE, INNER SALT

2-METHYL-5-PHENYL-3-(3-SULFOPROPYL)BENZOXAZOLIUM HYDROXIDE, INNER SALT

C17H17NO4S (331.08782420000006)


   

4-{5-[(2-Chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride (1:1)

4-{5-[(2-Chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride (1:1)

C14H19Cl2N3O2 (331.0854254)


   

S-BENZYL-L-CYSTEINE-4-NITROANILINE

(R)-2-Amino-3-benzylthio-N-(4-nitrophenyl)propionamide

C16H17N3O3S (331.09905720000006)


   

l-homocysteinesulfinic acid

l-homocysteinesulfinic acid

C18H21NO5 (331.1419656)


   

(+/-)-TRANS-2-BUTYLCYCLOHEXANOL

(+/-)-TRANS-2-BUTYLCYCLOHEXANOL

C16H25NO2S.HCl (331.1372686)


   

Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid)

Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid)

C17H21N3O4 (331.15319860000005)


   

(Z)-N-[(5-Chloro-2-hydroxyphenyl)(phenyl)methylene]-L-valine

(Z)-N-[(5-Chloro-2-hydroxyphenyl)(phenyl)methylene]-L-valine

C18H18ClNO3 (331.0975148)


   

9,9-Spirobi[9H-fluoren]-4-amine

9,9-Spirobi[9H-fluoren]-4-amine

C25H17N (331.1360922)


   

2-Isopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

2-Isopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

C15H21BF3NO3 (331.15665020000006)


   

N-(3-(BENZYLCARBAMOYL)PHENYL)NICOTINAMIDE

N-(3-(BENZYLCARBAMOYL)PHENYL)NICOTINAMIDE

C20H17N3O2 (331.1320702)


   
   

(R)-8-(Diphenylphosphino)-1,2,3,4-tetrahydronaphthalen-1-amine

(R)-8-(Diphenylphosphino)-1,2,3,4-tetrahydronaphthalen-1-amine

C22H22NP (331.14897820000004)


   

[4-(4-chloro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

[4-(4-chloro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

C17H18ClN3O2 (331.1087478)


   

(R)-3-PHENYL-3-(4-TRIFLUOROMETHYL-PHENOXY)-PROPYLAMINE HYDROCHLORIDE

(R)-3-PHENYL-3-(4-TRIFLUOROMETHYL-PHENOXY)-PROPYLAMINE HYDROCHLORIDE

C16H17ClF3NO (331.09506980000003)


   

diethyl 2-[[4-(trifluoromethyl)anilino]methylidene]propanedioate

diethyl 2-[[4-(trifluoromethyl)anilino]methylidene]propanedioate

C15H16F3NO4 (331.10313720000005)


   
   

PJ34 HCl

2-(Dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide hydrochloride

C17H18ClN3O2 (331.1087478)


   

Aminodi(ethyloxy)ethylaminocarbonylbenzenesulfonamide

Aminodi(ethyloxy)ethylaminocarbonylbenzenesulfonamide

C13H21N3O5S (331.1201856)


   

2-[(5,6-Diphenylfuro[2,3-D]pyrimidin-4-YL)amino]ethanol

2-[(5,6-Diphenylfuro[2,3-D]pyrimidin-4-YL)amino]ethanol

C20H17N3O2 (331.1320702)


   

5-(((Carboxymethyl)amino)methyl)uridine

5-(((Carboxymethyl)amino)methyl)uridine

C12H17N3O8 (331.1015602)


   

(S)-2-Amino-3-benzylthio-N-(4-nitrophenyl)propionamide

(S)-2-Amino-3-benzylthio-N-(4-nitrophenyl)propionamide

C16H17N3O3S (331.09905720000006)


   
   

Glypinamide

Glypinamide

C13H18ClN3O3S (331.0757348)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   
   
   

N-[[2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

N-[[2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

C16H17N3OS2 (331.0812992)


   

2-[(3-butyl-4-oxo-2-quinazolinyl)thio]-N-cyclopropylacetamide

2-[(3-butyl-4-oxo-2-quinazolinyl)thio]-N-cyclopropylacetamide

C17H21N3O2S (331.13544060000004)


   

Carbamimidothioic acid 2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl ester

Carbamimidothioic acid 2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl ester

C16H17N3O3S (331.09905720000006)


   

4-amino-6,7-diphenyl-2(1H)-pteridinethione

4-amino-6,7-diphenyl-2(1H)-pteridinethione

C18H13N5S (331.08916180000006)


   

(E)-3-(3-(N-(2-hydroxyethyl)sulfamoyl)-4,5-dimethoxyphenyl)acrylic acid

(E)-3-(3-(N-(2-hydroxyethyl)sulfamoyl)-4,5-dimethoxyphenyl)acrylic acid

C13H17NO7S (331.07256920000003)


   

5-[1-[(4-Methylphenyl)methyl]-3-pyrazolyl]-2-phenylthiazole

5-[1-[(4-Methylphenyl)methyl]-3-pyrazolyl]-2-phenylthiazole

C20H17N3S (331.11431220000003)


   

3-phenyl-4-[[4-(trifluoromethyl)anilino]methylidene]-1H-pyrazol-5-one

3-phenyl-4-[[4-(trifluoromethyl)anilino]methylidene]-1H-pyrazol-5-one

C17H12F3N3O (331.0932418)


   

3,6-Diamino-9-(2-carboxyphenyl)xanthenium

3,6-Diamino-9-(2-carboxyphenyl)xanthenium

C20H15N2O3+ (331.10826199999997)


   
   

2-Hydroxy-5-[4-(2-hydroxy-ethyl)-piperidin-1-YL]-5-phenyl-1H-pyrimidine-4,6-dione

2-Hydroxy-5-[4-(2-hydroxy-ethyl)-piperidin-1-YL]-5-phenyl-1H-pyrimidine-4,6-dione

C17H21N3O4 (331.15319860000005)


   

2-[(Phenylsulfonyl)amino]-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid

2-[(Phenylsulfonyl)amino]-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid

C17H17NO4S (331.08782420000006)


   

N-1H-imidazol-2-yl-N-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine

N-1H-imidazol-2-yl-N-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine

C18H17N7 (331.1545362)


   

(5-Phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol

(5-Phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol

C19H17N5O (331.1433032)


   

6-([5-Quinolylamino]methyl)-2,4-diamino-5-methylpyrido[2,3-D]pyrimidine

6-([5-Quinolylamino]methyl)-2,4-diamino-5-methylpyrido[2,3-D]pyrimidine

C18H17N7 (331.1545362)


   

4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate

4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate

C16H15N2O4S- (331.07524900000004)


   

5'-O-beta-D-Glucosylpyridoxine

2-{[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C14H21NO8 (331.1267106)


   

(2S,3S)-2-(2,4-Difluorophenyl)-3-methylsulfonyl-1-(1,2,4-triazol-1-yl)butan-2-ol

Threo-2-(2,4-difluorophenyl)-3-methylsulfonyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

C13H15F2N3O3S (331.08021440000005)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

   

1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-ylquinoline-3-carboxylate

1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-ylquinoline-3-carboxylate

C17H18FN3O3 (331.13321300000007)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Sulochrin(1-)

Sulochrin(1-)

C17H15O7- (331.081774)


A phenolate anion that is the conjugate base of sulochrin, obtained by deprotonation of one of the phenolic hydroxy groups; major species at pH 7.3.

   
   

carlactone carboxylate

carlactone carboxylate

C19H23O5- (331.1545408)


   

5-Carboxymethylaminomethyluridine

5-Carboxymethylaminomethyluridine

C12H17N3O8 (331.1015602)


   

(1R,2R,5S,8S,9S,10R,11S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5S,8S,9S,10R,11S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545408)


   

(1R,2R,5R,8R,9S,10R,11S,13R)-13-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5R,8R,9S,10R,11S,13R)-13-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545408)


   

(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545408)


   

4-{[(2R,3R,4S,5R)-5-acetamido-4,6-dihydroxy-2-methyloxan-3-yl]carbamoyl}-2-oxobutanoate

4-{[(2R,3R,4S,5R)-5-acetamido-4,6-dihydroxy-2-methyloxan-3-yl]carbamoyl}-2-oxobutanoate

C13H19N2O8- (331.1141354)


   

16alpha, 17-epoxy GA9

16alpha, 17-epoxy GA9

C19H23O5- (331.1545408)


   

pyruvoyl-L-leucyl-L-methionine

pyruvoyl-L-leucyl-L-methionine

C14H23N2O5S- (331.1327608)


   

(-)-trans-4-[4-(4-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite)

(-)-trans-4-[4-(4-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite)

C19H22FNO3 (331.1583634)


   

N-Hydroxyneosaxitoxin

N-Hydroxyneosaxitoxin

C10H17N7O6 (331.1240262)


   

6-[[5-Hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxymethyl]oxane-2,3,4,5-tetrol

6-[[5-Hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxymethyl]oxane-2,3,4,5-tetrol

C14H21NO8 (331.1267106)


   

6-Hydroxyoct-2-enedioylcarnitine

6-Hydroxyoct-2-enedioylcarnitine

C15H25NO7 (331.163094)


   

6-Hydroxyoct-3-enedioylcarnitine

6-Hydroxyoct-3-enedioylcarnitine

C15H25NO7 (331.163094)


   

7-Hydroxyoct-3-enedioylcarnitine

7-Hydroxyoct-3-enedioylcarnitine

C15H25NO7 (331.163094)


   

7-Hydroxyoct-4-enedioylcarnitine

7-Hydroxyoct-4-enedioylcarnitine

C15H25NO7 (331.163094)


   

5-Hydroxyoct-2-enedioylcarnitine

5-Hydroxyoct-2-enedioylcarnitine

C15H25NO7 (331.163094)


   

Sekisanolin

8H-[1,3]Dioxolo[6,7][2]benzopyrano[3,4-c]indol-6a(3H)-ol,4,4a,5,6-tetrahydro-3-methoxy-5-methyl-, (3S,4aS,6aS,13bS)-

C18H21NO5 (331.1419656)


   

Prothiaden

Dosulepin hydrochloride

C19H22ClNS (331.1161402000001)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

Acetic acid [2-[[(6,6-dimethoxy-3-oxo-1-cyclohexa-1,4-dienyl)amino]-oxomethyl]phenyl] ester

Acetic acid [2-[[(6,6-dimethoxy-3-oxo-1-cyclohexa-1,4-dienyl)amino]-oxomethyl]phenyl] ester

C17H17NO6 (331.1055822)


   

2-[(Z)-(2-oxo-1-propan-2-ylindol-3-ylidene)methyl]-1H-quinazolin-4-one

2-[(Z)-(2-oxo-1-propan-2-ylindol-3-ylidene)methyl]-1H-quinazolin-4-one

C20H17N3O2 (331.1320702)


   

N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-4-pyridinecarboxamide

N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-4-pyridinecarboxamide

C19H17N5O (331.1433032)


   

gibberellin A4(1-)

gibberellin A4(1-)

C19H23O5- (331.1545408)


A gibberellin carboxylic acid anion that is the conjugate base of gibberellin A4, obtained by deprotonation of the carboxy group.

   

gibberellin A20(1-)

gibberellin A20(1-)

C19H23O5- (331.1545408)


Conjugate base of gibberellin A20.

   

(15R)-9,15-Dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.01,13.02,10.04,8]nonadeca-2,4(8),9,16-tetraen-18-ol

(15R)-9,15-Dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.01,13.02,10.04,8]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.1419656)


   

N-[4-(1-piperidinyl)phenyl]-2-quinolinecarboxamide

N-[4-(1-piperidinyl)phenyl]-2-quinolinecarboxamide

C21H21N3O (331.1684536)


   

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-morpholinyl)-5-pyrimidinecarboxylic acid ethyl ester

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-morpholinyl)-5-pyrimidinecarboxylic acid ethyl ester

C16H21N5O3 (331.16443160000006)


   

2-[1-[2-(1-Benzothiophen-5-ylamino)-2-oxoethyl]cyclohexyl]acetic acid

2-[1-[2-(1-Benzothiophen-5-ylamino)-2-oxoethyl]cyclohexyl]acetic acid

C18H21NO3S (331.12420760000003)


   

10-Piperidin-1-yl-15,16-diazatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2,4,6,9,11,13(17)-heptaene-8,14-dione

10-Piperidin-1-yl-15,16-diazatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2,4,6,9,11,13(17)-heptaene-8,14-dione

C20H17N3O2 (331.1320702)


   

2-[(6-ethyl-4-methylquinazolin-2-yl)amino]quinazolin-4(1H)-one

2-[(6-ethyl-4-methylquinazolin-2-yl)amino]quinazolin-4(1H)-one

C19H17N5O (331.1433032)


   

N-{2-[(4-methylphenyl)carbamoyl]phenyl}pyridine-3-carboxamide

N-{2-[(4-methylphenyl)carbamoyl]phenyl}pyridine-3-carboxamide

C20H17N3O2 (331.1320702)


   

1-[4-(4-Ethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(4-Ethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

C17H21N3O2S (331.13544060000004)


   

1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-3,4-dihydro-2H-azepin-7-one

1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-3,4-dihydro-2H-azepin-7-one

C18H21NO5 (331.1419656)


   
   

1-Tert-butyl-5-[(4-ethoxyanilino)methylidene]-1,3-diazinane-2,4,6-trione

1-Tert-butyl-5-[(4-ethoxyanilino)methylidene]-1,3-diazinane-2,4,6-trione

C17H21N3O4 (331.15319860000005)


   

5-(4-Methylpiperidin-1-yl)-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile

5-(4-Methylpiperidin-1-yl)-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile

C21H21N3O (331.1684536)


   

N-[1-[(4-methylphenyl)methyl]-2-benzimidazolyl]-2-furancarboxamide

N-[1-[(4-methylphenyl)methyl]-2-benzimidazolyl]-2-furancarboxamide

C20H17N3O2 (331.1320702)


   

2-[(5,5-dimethyl-6H-[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)thio]acetic acid propan-2-yl ester

2-[(5,5-dimethyl-6H-[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)thio]acetic acid propan-2-yl ester

C17H21N3O2S (331.13544060000004)


   

5-(3-chlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

5-(3-chlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

C15H14ClN5O2 (331.0835974)


   

6-(3-methylphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

6-(3-methylphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C20H17N3S (331.11431220000003)


   

1,7,7-trimethyl-N-(4-nitrophenyl)-2-oxo-4-bicyclo[2.2.1]heptanecarbohydrazide

1,7,7-trimethyl-N-(4-nitrophenyl)-2-oxo-4-bicyclo[2.2.1]heptanecarbohydrazide

C17H21N3O4 (331.15319860000005)


   

1-[2-(4-chlorophenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol

1-[2-(4-chlorophenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol

C19H22ClNO2 (331.13389820000003)


   

N-{4-[N-(phenylsulfonyl)ethanehydrazonoyl]phenyl}acetamide

N-{4-[N-(phenylsulfonyl)ethanehydrazonoyl]phenyl}acetamide

C16H17N3O3S (331.09905720000006)


   

2-Ethoxy-3-pyridinecarboxylic acid (6-chloro-2-imidazo[1,2-a]pyridinyl)methyl ester

2-Ethoxy-3-pyridinecarboxylic acid (6-chloro-2-imidazo[1,2-a]pyridinyl)methyl ester

C16H14ClN3O3 (331.07236439999997)


   

5-[(3-Methylphenoxy)methyl]-3-[4-(1-pyrrolyl)phenyl]-1,2,4-oxadiazole

5-[(3-Methylphenoxy)methyl]-3-[4-(1-pyrrolyl)phenyl]-1,2,4-oxadiazole

C20H17N3O2 (331.1320702)


   

5-[[2-Methoxy-4-(4-morpholinyl)phenyl]methylidene]-1,3-diazinane-2,4,6-trione

5-[[2-Methoxy-4-(4-morpholinyl)phenyl]methylidene]-1,3-diazinane-2,4,6-trione

C16H17N3O5 (331.1168152)


   

N-(3-bicyclo[2.2.1]heptanyl)-2-[5-(4-chlorophenyl)-2-tetrazolyl]acetamide

N-(3-bicyclo[2.2.1]heptanyl)-2-[5-(4-chlorophenyl)-2-tetrazolyl]acetamide

C16H18ClN5O (331.1199808)


   

4-[5-(3-Hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl)-2-furanyl]benzonitrile

4-[5-(3-Hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl)-2-furanyl]benzonitrile

C19H13N3O3 (331.09568680000007)


   

2-[(2Z)-2-(6-methoxy-3,4-dihydro-2H-naphthalen-1-ylidene)hydrazinyl]-1,3-thiazole-4-carbohydrazide

2-[(2Z)-2-(6-methoxy-3,4-dihydro-2H-naphthalen-1-ylidene)hydrazinyl]-1,3-thiazole-4-carbohydrazide

C15H17N5O2S (331.1102902)


   
   
   
   

2-[[(4-Tert-butylphenyl)-oxomethyl]amino]-4-chlorobenzoic acid

2-[[(4-Tert-butylphenyl)-oxomethyl]amino]-4-chlorobenzoic acid

C18H18ClNO3 (331.0975148)


   

7-ethoxy-3-(2-methoxyethyl)-N-methyl-4H-[1,3]thiazino[6,5-b]quinolin-2-imine

7-ethoxy-3-(2-methoxyethyl)-N-methyl-4H-[1,3]thiazino[6,5-b]quinolin-2-imine

C17H21N3O2S (331.13544060000004)


   

1-(4-Chlorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol

1-(4-Chlorophenyl)-3-(4-morpholinyl)-2-phenyl-1-propanol

C19H22ClNO2 (331.13389820000003)


   

Methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate hydrochloride

Methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate hydrochloride

C16H26ClNO4 (331.15502660000004)


   

(9Z)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-2-ol

(9Z)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-2-ol

C18H18ClNOS (331.07975680000004)


   

6-{Hydroxy[(4-nitrobenzyl)oxy]phosphoryl}hexanoic acid

6-{Hydroxy[(4-nitrobenzyl)oxy]phosphoryl}hexanoic acid

C13H18NO7P (331.0820848)


   

(11R)-carlactonoate

(11R)-carlactonoate

C19H23O5- (331.1545408)


   

1-[[4-[(E)-hydroxyiminomethyl]-2-[(Z)-hydroxyiminomethyl]pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-4-carboxamide

1-[[4-[(E)-hydroxyiminomethyl]-2-[(Z)-hydroxyiminomethyl]pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-4-carboxamide

C15H17N5O4+2 (331.1280482)


   

2-methyl-5-oxo-4-thiophen-2-yl-4,6,7,8-tetrahydro-3H-quinoline-3-carboxylic acid propyl ester

2-methyl-5-oxo-4-thiophen-2-yl-4,6,7,8-tetrahydro-3H-quinoline-3-carboxylic acid propyl ester

C18H21NO3S (331.12420760000003)


   

4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]butanoic acid

4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]butanoic acid

C17H17NO4S (331.08782420000006)


   

(3Z)-3-[(10S)-2-chloro-10-oxothioxanthen-9-ylidene]-N,N-dimethylpropan-1-amine

(3Z)-3-[(10S)-2-chloro-10-oxothioxanthen-9-ylidene]-N,N-dimethylpropan-1-amine

C18H18ClNOS (331.07975680000004)


   

2,5-Dihydroxy-4-(2-hydroxyphenyl)-5-(methylamino)-3-phenylpentanoic acid

2,5-Dihydroxy-4-(2-hydroxyphenyl)-5-(methylamino)-3-phenylpentanoic acid

C18H21NO5 (331.1419656)


   

N(2)-[4-(indol-3-yl)butanoyl]-L-glutamine

N(2)-[4-(indol-3-yl)butanoyl]-L-glutamine

C17H21N3O4 (331.15319860000005)


   

(9E)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-1-ol

(9E)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-1-ol

C18H18ClNOS (331.07975680000004)


   

(2S)-N-[2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]ethyl]-2-methylpiperidine-1-carboxamide

(2S)-N-[2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]ethyl]-2-methylpiperidine-1-carboxamide

C18H22FN3O2 (331.1695964)


   
   

3,4-Bis(methoxycarbonyl)-2-trimethylsilyl-5-phenylpyrrole

3,4-Bis(methoxycarbonyl)-2-trimethylsilyl-5-phenylpyrrole

C17H21NO4Si (331.1239786)


   

1-(Chloromethyl(para-tolyl)silyl)-2-(methyl(para-tolyl)silyl)ethane

1-(Chloromethyl(para-tolyl)silyl)-2-(methyl(para-tolyl)silyl)ethane

C18H24ClSi2 (331.1104994)


   

5-O-beta-D-Glucosylpyridoxine

5-O-beta-D-Glucosylpyridoxine

C14H21NO8 (331.1267106)


   
   

Didesethylflurazepam

Didesethylflurazepam

C17H15ClFN3O (331.0887622)


A primary amino compound resulting from the dealkylation of both ethyl groups of the anti-insomnia drug flurazepam. It is the major metabolite of flurazepam.

   

N-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

N-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

C16H14ClN3O3 (331.07236439999997)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   
   

1-cyclopropyl-2-(2-fluorophenyl)-2-{2-hydroxy-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}ethan-1-one

1-cyclopropyl-2-(2-fluorophenyl)-2-{2-hydroxy-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}ethan-1-one

C18H18FNO2S (331.10422200000005)


   
   

BRL-44408 (maleate)

BRL-44408 (maleate)

C17H21N3O4 (331.15319860000005)


BRL-44408 maleate is an α2A-adrenoceptor antagonist (Ki: 8.5 nM). BRL-44408 maleate has antidepressant and analgesic activity. BRL-44408 also improves cecal ligation puncture (CLP)-induced acute lung injury[1][2].

   

GAC0001E5

GAC0001E5

C17H12F3N3O (331.0932418)


GAC0001E5 is an LXR inverse agonist. GAC0001E5 has antiproliferative activity and can be used in cancer research[1].

   

Sirtuin-1 inhibitor 1

Sirtuin-1 inhibitor 1

C20H17N3O2 (331.1320702)


Sirtuin-1 inhibitor 1 (Compound 8) is an inhibitor of Sirtuin-1 that plays important roles in obesity-induced diabetes and aging-related diseases[1].

   

SW157765

SW157765

C19H13N3O3 (331.09568680000007)


SW157765 is a selective non-canonical glucose transporter GLUT8 (SLC2A8) inhibitor. KRAS/KEAP1 double mutant NSCLC cells are selectively sensitive to the SW157765, due to the convergent consequences of dual KRAS and NRF2 modulation of metabolic and xenobiotic gene regulatory programs[1][2].

   

(1s,13s,16r,18s)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraen-13-ol

(1s,13s,16r,18s)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraen-13-ol

C18H21NO5 (331.1419656)


   

2,6-dimethyl-8-(1,4,6-trihydroxy-3h-isoindol-5-yl)octa-2,6-dienoic acid

2,6-dimethyl-8-(1,4,6-trihydroxy-3h-isoindol-5-yl)octa-2,6-dienoic acid

C18H21NO5 (331.1419656)


   

(2z,4z)-n-[2-(acetyloxy)-2-methylpropyl]-5-(2h-1,3-benzodioxol-5-yl)penta-2,4-dienimidic acid

(2z,4z)-n-[2-(acetyloxy)-2-methylpropyl]-5-(2h-1,3-benzodioxol-5-yl)penta-2,4-dienimidic acid

C18H21NO5 (331.1419656)


   

(3as)-6-hydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

(3as)-6-hydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

C20H13NO4 (331.08445380000006)


   

(1s,13s,15r,19r)-19-hydroxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-yl acetate

(1s,13s,15r,19r)-19-hydroxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-yl acetate

C18H21NO5 (331.1419656)


   

1-hydroxy-2,3,5,6-tetramethoxy-10h-acridin-9-one

1-hydroxy-2,3,5,6-tetramethoxy-10h-acridin-9-one

C17H17NO6 (331.1055822)


   

9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.1419656)


   

11-hydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one

11-hydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one

C20H17N3O2 (331.1320702)


   

(11s,12s,15s)-13-methoxy-5,7,21-trioxa-19-azahexacyclo[11.7.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹⁵,¹⁹]henicosa-2,4(8),9-trien-12-ol

(11s,12s,15s)-13-methoxy-5,7,21-trioxa-19-azahexacyclo[11.7.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹⁵,¹⁹]henicosa-2,4(8),9-trien-12-ol

C18H21NO5 (331.1419656)


   

[(1s)-1-[5-(1h-indol-3-yl)-1,3-oxazol-2-yl]-2-phenylethyl]dimethylamine

[(1s)-1-[5-(1h-indol-3-yl)-1,3-oxazol-2-yl]-2-phenylethyl]dimethylamine

C21H21N3O (331.1684536)


   

5-hydroxy-4,11-dimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-8-one

5-hydroxy-4,11-dimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-8-one

C18H21NO5 (331.1419656)


   

1-chloro-n-[(1e,6r,10r)-6,10-dihydroxy-11-methyl-3,7-dimethylidenedodeca-1,11-dien-1-yl]methanecarbonimidoyl chloride

1-chloro-n-[(1e,6r,10r)-6,10-dihydroxy-11-methyl-3,7-dimethylidenedodeca-1,11-dien-1-yl]methanecarbonimidoyl chloride

C16H23Cl2NO2 (331.1105758)


   

10,11,12,13-tetrahydroxy-11-(hydroxymethyl)-6-imino-3-oxa-5,7-diazatetracyclo[7.4.0.0¹,⁴.0⁴,⁸]tridecane-2-carboxylic acid

10,11,12,13-tetrahydroxy-11-(hydroxymethyl)-6-imino-3-oxa-5,7-diazatetracyclo[7.4.0.0¹,⁴.0⁴,⁸]tridecane-2-carboxylic acid

C12H17N3O8 (331.1015602)


   
   

(1s,11s,13s,15s,18s)-11,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

(1s,11s,13s,15s,18s)-11,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.1419656)


   

(1r,13r,15r,18s)-9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

(1r,13r,15r,18s)-9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.1419656)


   

1,6-dihydroxy-2,3,5-trimethoxy-10-methylacridin-9-one

1,6-dihydroxy-2,3,5-trimethoxy-10-methylacridin-9-one

C17H17NO6 (331.1055822)